Initial imaging recommendations for Vasovist angiography

European Radiology, Supplement

Volumn 16, Issue SUPPL. 2, 2006, Pages

  Hartmann, M ^a   Wiethoff, A J ^a   Hentrich, H R ^a   Rohrer, M ^a  

^a EPIX Pharmaceuticals   (United States)

Author keywords

Blood pool agent; Extended phase imaging; Extracellular contrast agent; First pass MRA agent; MR angiography; Vascular disease

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOFOSVESET; GADOLINIUM; ORGANOMETALLIC COMPOUND;

COMPARATIVE STUDY; FEMALE; HUMAN; IMAGE QUALITY; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASE;

CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; ORGANOMETALLIC COMPOUNDS; RADIOGRAPHIC IMAGE ENHANCEMENT; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASES;

EID: 33745931761     PISSN: 16133749     EISSN: 16133757     Source Type: Journal    
DOI: 10.1007/s10406-006-0163-8     Document Type: Review

References (14)

1. Farooki A, Narra V, Brown J (2004) Gadofosveset (EPIX/Schering). Curr Opin Investig Drugs 5:967-976
2. Parmelee DJ, Walovitch RC, Ouellet HS, Lauffer RB (1997) Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol 32:741-747
3. Caravan P, Cloutier NJ, Greenfield MT et al. (2002) The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. JACS 124:3152-3162
4. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Ra-diol 40:715-724
5. Prince MR, Grist TM, Debatin JF (2003) 3D contrast MR angiography (3rd edn). Springer, Berlin Heidelberg New York
6. Perreault P, Edelman MA, Baum RA et al. (2003) MR angiography with gado-fosveset trisodium for peripheral vascular disease: phase II trial. Radiology 229:811-820
7. Bluemke DA, Stillman AE, Bis KG et al. (2001) Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology 219:114-122
8. Grist TM, Korosec FR, Peters DC et al. (1998) Steady-state and dynamic MR an-giography with MS-325: initial experience in humans. Radiology 207:539-544
9. Rapp JH, Wolff SD, Quinn SF et al. (2005) Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography-multicenter comparative phase III study. Radiology 236:71-78
10. Goyen M, Edelman M, Perreault P et al. (2005) MR angiography of aortoili-ac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 236:825-833
11. de Haan MW, Kouwenhoven M, Kessels AG, van Engelshoven JM (2000) Renal artery blood flow: quantification with breath-hold or respiratory triggered phase contrast MR imaging. Eur Radiol. 10:1133-1137
12. Spuentrup E, Manning WJ, Bornert P, Kissinger KV, Botnar RM, Stuber M (2002) Renal arteries: navigator-gated balanced fast field-echo projection MR angiography with aortic spin labeling: initial experience. Radiology 225:589-596
13. Wilson GJ, Hoogeveen RM, Willinek WA, Muthupillai R, Maki JH (2004) Parallel imaging in MR angiography. Top Magn Reson Imaging 15:169-185
14. Nikolaou K, Kramer H, Grosse C, Clevert D, MD, Dietrich O, Hartmann M, Chamberlin P, Reiser MF, Schoen-berg SO (2006) High-resolution whole-body MRA using parallel imaging on a 32-channel MR system and a blood pool contrast agent: protocol optimization and clinical implementation. Radiology (in press